Skip to content
Home/Companies/Healthcare/AmWell

AmWell

Healthcare·US·Exited 2020·Held 2yr
Entry
2018
Hold
2yr
Exit
2020

Who owns AmWell?

AmWell was owned by Yaday through AA Sons Legacy (2016 vintage) from 2018 to 2020, exited via IPO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Yaday
Investor
Yaday
AA Sons Legacy · 2016 · VC

Key facts

HQUSA
SectorHealthcare
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2020

More from AA Sons Legacy

Other portfolio companies in the same fund.

Stage11
Stage11
Active
TMTFrance· 2022
Aeler
Aeler
Active
IndustrialsSwitzerland· 2021
AnnaBella
AnnaBella
Active
ConsumerFrance· 2021
BodyVision Medical
BodyVision Medical
Active
HealthcareIsrael· 2021
Bruvi
Bruvi
Active
ConsumerUS· 2021
Cashbee
Cashbee
Active
FinancialsFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track AmWell

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy AmWell?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on AmWell.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue